RAKESH M SURI, M.D.
Radiology at 1 St, Rochester, MN

License number
Minnesota 46119
Category
Radiology
Type
Surgery
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511

Organization information

See more information about RAKESH M SURI at bizstanding.com

Mayo Clinic - Rakesh M Suri MD

200 1 St SW #W4, Rochester, MN 55905

Categories:
General Surgeons
Phone:
(507) 255-7067 (Phone)

Professional information

Rakesh M Suri Photo 1

Dr. Rakesh M Suri, Rochester MN - MD (Doctor of Medicine)

Specialties:
Cardiac Surgery
Address:
Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Procedures:
Coronary Angioplasty, Atherectomy and Stent
Conditions:
Congestive Heart Failure, Heart Attack (Acute Myocardial Infarction)
Certifications:
Thoracic Cardiovascular Surgery, 2007
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mayo Clinic
200 1St St SW, Rochester 55905
Mayo Clinic Saint Marys Hospital
1216 2Nd St South #West, Rochester 55902
Education:
Medical School
University Of Toronto Faculty Of Medicine
Mayo School Of Graduate Med Education
Graduated: 2005
University Of Toronto
Graduated: 2002


Rakesh Mark Suri Photo 2

Rakesh Mark Suri, Rochester MN

Specialties:
Thoracic Surgery, Cardiothoracic Vascular Surgery, Surgery
Work:
Mayo Medical School
200 1St St Sw, Rochester, MN 55905
Education:
University Of Toronto Faculty Of Medicine


Rakesh Suri Photo 3

Expandable Valve Prosthesis With Sealing Mechanism

US Patent:
2009009, Apr 16, 2009
Filed:
Oct 12, 2007
Appl. No.:
11/871447
Inventors:
Rakesh M. Suri - Rochester MN, US
W. Andrew Ziarno - Milano, IT
Eric Manasse - Milano, IT
Assignee:
Sorin Biomedica Cardio S.r.l. - Saluggia (Vercelli)
International Classification:
A61F 2/24
US Classification:
623 211, 623 21
Abstract:
A prosthetic heart valve includes at least one sealing member. The sealing member is adapted to conform to any surface irregularities found on the inner surface of the valve annulus, including any calcium deposits formed on the valve leaflets. The sealing member can be self-expanding or non-expanding. When deployed, the sealing member is adapted to create a blood tight seal between the prosthetic heart valve and the inner surface of the valve annulus thereby minimizing and/or eliminating perivalvular leakage at the implantation site.


Rakesh Suri Photo 4

Microprocessor Controlled Delivery System For Cardiac Valve Prosthesis

US Patent:
2009010, Apr 23, 2009
Filed:
Sep 5, 2008
Appl. No.:
12/205144
Inventors:
W. Andrew Ziarno - Milano, IT
Rakesh M. Suri - Rochester MN, US
Eric Manasse - Milano, IT
International Classification:
A61N 1/00, A61B 5/02, A61F 2/24, A61B 19/00
US Classification:
607120, 600481, 623 21, 128898
Abstract:
An instrument for deploying a cardiac valve prosthesis, including a plurality of radially expandable portions, at an implantation site, includes a plurality of deployment elements each independently operable to obtain the radial expansion of a radially expandable portion of the valve prosthesis. The instrument includes a microprocessor configured to processes signals from one or more sensors and to optimize deployment of the valve prosthesis.


Rakesh Suri Photo 5

Minimally Invasive Aortic Valve Replacement

US Patent:
2011008, Apr 7, 2011
Filed:
Oct 5, 2010
Appl. No.:
12/897937
Inventors:
Rakesh M. Suri - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61F 2/24
US Classification:
623 211
Abstract:
A minimally invasive method of implanting a prosthetic aortic valve includes forming a surgical site within a patient's chest that includes a first access port, a second access port, a viewing port and a delivery port. A camera is inserted into the viewing port. The native aortic valve leaflets may each be grasped and removed via tools inserted through the first and second access ports. The prosthetic aortic valve may be delivered through the delivery port to the valve annulus using a delivery device. The prosthetic aortic valve is implanted at the valve annulus and the delivery device is withdrawn. A surgeon may perform the remotely operated steps while viewing images provided by the camera.


Rakesh Suri Photo 6

Streamlined Delivery System For In Situ Deployment Of Cardiac Valve Prostheses

US Patent:
8475521, Jul 2, 2013
Filed:
Jun 27, 2008
Appl. No.:
12/147560
Inventors:
Rakesh M. Suri - Rochester MN, US
Franco Vallana - Turin, IT
Giovanni Rolando - Chivasso, IT
Giovanni Righini - Chivasso, IT
Brent R. Phillips - Rochester MN, US
Eric Manasse - Milan, IT
Assignee:
Sorin Group Italia S.r.l. - Milan
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61F 2/24, A61F 2/06
US Classification:
623 211, 623 111
Abstract:
A system for implanting a heart valve prosthesis in a patient's heart includes a balloon expandable, tissue, stented heart valve and a transfemoral valve delivery device for delivering the stented heart valve to a target site in the patient's heart. The delivery device includes an inflation balloon module for expanding the stented heart valve prosthesis, markers on to assist in location of the delivery device at an appropriate location; and a streamlined cap.


Rakesh Suri Photo 7

Streamlined, Apical Delivery System For In Situ Deployment Of Cardiac Valve Prostheses

US Patent:
8486137, Jul 16, 2013
Filed:
Jun 27, 2008
Appl. No.:
12/147558
Inventors:
Rakesh M. Suri - Rochester MN, US
Franco Vallana - Turin, IT
Giovanni Rolando - Chivasso, IT
Giovanni Righini - Chivasso, IT
Brent R. Phillips - Rochester MN, US
Eric Manasse - Milan, IT
Assignee:
Sorin Group Italia S.r.l. - Milan
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61F 2/24
US Classification:
623 211, 623 111
Abstract:
A system for implanting a heart valve prosthesis in a patient's heart includes a balloon expandable, tissue, stented heart valve, and an apical valve delivery device for delivering the stented heart valve to a target site in the patient's heart. The delivery device includes an inflation balloon module for expanding the stented heart valve prosthesis, markers on the delivery device to assist in location of the delivery device at an appropriate location, and a streamlined cap.


Rakesh Suri Photo 8

Prosthetic Valve Delivery System Including Retrograde/Antegrade Approach

US Patent:
2009006, Mar 12, 2009
Filed:
Sep 7, 2007
Appl. No.:
11/851523
Inventors:
Rakesh M. Suri - Rochester MN, US
Franco Vallana - Torino, IT
Giovanni Roloando - Chavasso-Torino, IT
Giovanni Righini - Chivasso-Torino, IT
Brent R. Phillips - Rochester MN, US
Assignee:
Sorin Biomedica Cardio S.r.l. - Saluggia
International Classification:
A61F 2/24
US Classification:
623 211
Abstract:
A device for implanting an expandable heart valve prosthesis at a valve annulus in a patient's heart includes an implantation device configured to extend from a first opening in the patient's body, through the patient's aorta, through a valve annulus, through an opening in a ventricle, and to exit through the patient's thoracic region. The device further includes a port having a hemostasis valve for providing access through the patient's thoracic region and into the ventricle and at least two interchangeable modules configured for delivery using the implantation device.


Rakesh Suri Photo 9

Fluid-Filled Delivery System For In Situ Deployment Of Cardiac Valve Prostheses

US Patent:
2009006, Mar 12, 2009
Filed:
Sep 7, 2007
Appl. No.:
11/851528
Inventors:
Giovanni Righini - Chivasso-Torino, IT
Rakesh M. Suri - Rochester MN, US
Assignee:
Sorin Biomedica Cardio S.r.I. - Saluggia
International Classification:
A61F 2/24
US Classification:
623 211
Abstract:
An instrument for deploying a cardiac valve prosthesis, including a plurality of radially expandable portions, at an implantation site, includes a plurality of deployment elements each independently operable to obtain the radial expansion of a radially expandable portion of the valve prosthesis. Additionally, the instrument is adapted to provide a de-aired, fluid-filled, or gas filled environment in order to minimize and/or prevent air embolism during the implantation procedure. The fluid can contain a drug. A method for deploying the cardiac valve prosthesis includes advancing the instrument to an implant site and independently actuating the radially expandable portions.